周二，由于拜登政府计划将减肥药纳入医保和补助计划，诺和诺德一度涨超3%，礼来一度涨近6.9%。在减肥药企普涨之际，安进公司（AMGN）却一度大跌超12.3%，原因是虽然安进的MariTide减肥药的疗效符合华尔街预期，但由于副作用较高且未能击败礼来公司的重磅药物Zepbound，且试验结果低于华尔街对MariTide的高预期。因为在数据公布前，甚至有分析师希望减重能达25%。安进表示，在为期一年的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.